Principal Securities’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.74M Sell
27,651
-2,674
-9% -$186K 0.03% 547
2025
Q4
$2.01M Buy
30,325
+24,429
+414% +$1.58M 0.03% 473
2025
Q3
$397K Buy
5,896
+124
+2% +$9.81K 0.01% 999
2025
Q2
$504K Buy
5,772
+1,703
+42% +$133K 0.01% 853
2025
Q1
$316K Hold
4,069
0.01% 951
2024
Q4
$316K Buy
4,069
+135
+3% +$9.99K 0.01% 947
2024
Q3
$264K Sell
3,934
-4,198
-52% -$345K 0.01% 995
2024
Q2
$922K Buy
8,132
+1,298
+19% +$164K 0.03% 496
2024
Q1
$948K Buy
6,834
+1,453
+27% +$183K 0.03% 469
2023
Q4
$668K Buy
+5,381
New +$550K 0.02% 511

Other funds holding DXCM

Principal Securities's DXCM Position: Q1 2026 in Review

Principal Securities reduced its DexCom (DXCM) stake by 8.8% in Q1 2026, selling an estimated $186K and leaving 27,651 shares worth $1.74M. The position accounts for 0.03% of the portfolio, ranked #547.

Principal Securities first reported a position in DXCM in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.01M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Principal Securities held 27,651 shares of DexCom worth $1.74M as of Q1 2026.
  • Principal Securities sold 2,674 DexCom shares in Q1 2026, an estimated $186K.
  • DexCom made up 0.03% of Principal Securities's portfolio in Q1 2026, its #547 holding.
  • Principal Securities first reported a position in DexCom in Q4 2023 and has held it in 10 quarters since.
  • Principal Securities's DexCom position peaked at $2.01M in Q4 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.